The model simulates an animal size B cell repertoire of 10 7 -10 8 B cells [24, 25] .
3 2
The life expectancy of unstimulated (naïve) B cells is 4.5 days. Naive B cells with 2 3 3 randomly generated immunoglobulin are created such that there is steady population of balanced so equal numbers of B cells are specific to each antigenic site of the antigen.
3 6
For all antigens in the population (P Ag ), the rate (P Ag gN) of naive B cell (N) decay was 2 3 7
set to (4.5 d) -1 (2a). The formation rate of naïve B cells (kN) was modeled as a first-2 3 8
order reaction where the rate was dependent on the naïve B cell population size (5x10 7 ) 2 3 9
per antigen in the population (P Ag )) and set to (4.6x105 h) -1 (2b). (eq. 4b) antibody secreting cells (P) dependent on the differentiation rate of δ (eq. 4c).
8 0
Apoptosis of germinal center B cells was modeled using a second-order equation 
Antibody is produced from antibody secreting cells with a decay rate based on a 2 9 4
half-life of 3 days. Each antibody in the simulation represents a large number of real 2 9 5
antibodies. Antibody production was dependent on presence of antibody secreting cells 2 9 6
(P s , P l ), which contain different decay rates. Antibody is production was modeled based 2 9 7 on a production rate, k Ab (eq. 5a). Short-lived antibody secreting cell (sP) decay was 2 9 8 modeled as a first-order reaction with a decay rate of gP s (eq 5b). Long-lived antibody 2 9 9 secreting cell decay was modeled as a first-order reaction with a decay rate of gP l (eq. ( (6))
Antibodies bind and remove antigen using a second-order reaction with a 3 2 0 reaction rate that is the function of the binding affinity between the antibody paratope 3 2 1
and antigen epitope, as well as the clearance and neutralization parameter (these 3 2 2
values were constant between all epitopes) (eq. 7a). Intrinsic antibody (Ab) decay was 3 2 3
based on a half-life of 10 days and modeled using a first-order rate equation dependent 3 2 4
on the decay rate g Ab (eq. 7b). Intrinsic antigen decay was modeled based on a half-life 3 2 5 of 12hrs and modeled using a first-order reaction dependent the antigen decay rate g Ag 3 2 6
(eq. 8). We first determined antigenic distances (AD) using protein sequence data for 11 3 9 8 HA proteins using the sequence-based antigenic distance approach previously occurs when an epitopic distance is seven or less in the model [17, 18] . SC18 and CA09 4 0 7 had four of the five head epitopes with an ED of less than or equal to seven, with the Sa 4 0 8 antigenic site having the least distance (Table 3) . Alternatively, SC18 and BR07 had 4 0 9 only one antigenic site with an ED of less than seven. Thus, in the model SC18 was 4 1 0 antigenically more similar to CA09 while BR07 was largely antigenically distinct (Table   4  1 (Fig 2A, S1 Fig A-D) and these similarities remained up until boosting (S1 Fig E-F) .
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Stalk-specific antibody and memory B cell counts were significantly less than head 4 4 3 antigenic sites making up about 10% of the total response and were similar for both 4 4 4 groups (S1 Fig E and F) . Overall, antibody and memory B cell counts and specificities to (Fig 2B-C) . The affinity of the cross-reactive memory B cells to CA09 was also 4 6 5 different between the groups, with the SC18 group having higher affinity compared to 4 6 6 the BR07 group (Fig 2D) . Therefore, although immune responses specific to the priming 4 6 7 antigen were similar between groups, cross-reactive antibody and memory B cells were 4 6 8 significantly different.
6 9
Next, we sought to determine the effect of priming on secondary immune 4 7 0 responses to CA09 and assess differences in B cell/antibody totals and antigenic site 4 7 1 specificities. After boosting with CA09, total antibody levels reactive to CA09 in the 4 7 2 SC18 group were higher compared to the BR07 group, although this difference did not 4 7 3 reach significance (S2 Fig A) . The SC18 primed group produced a Sa-antigenic-site 4 7 4 dominant response to CA09 with Sb and Cb antigenic-site specific antibodies also 4 7 5 boosted (Fig 2A) . Stalk antigenic site antibody was also boosted but to a lesser extent 4 7 6 than the head epitopes making up about 15% of the antibody response (Fig 2E) . In 4 7 7 contrast, stalk-specific antibody responses for the BR07 primed group dominated (Fig   4  7  8 2A) comprising 35% of the total antibody response (Fig 2E) and showed a more 4 7 9 moderate increase in other antigenic site specific antibodies (Fig 2A) . These antigenic 4 8 0 site-specific differences between groups generally corresponded to differences in 4 8 1 epitopic distances between the primary and secondary antigen (Table 3) reactive responses to all antigens compared to the SC18 group with 20% of the 5 1 0 antibodies cross-reactive to all 11 strains (Fig 3B) . Additionally, cross-reactivity to 5-7 5 1 1 strains was also boosted indicating that the increase in cross-reactivity in the BR07 5 1 2 group was not only due to boosting of stalk-specific antibodies but also increased cross-5 1 3 reactivity of antibodies specific to the HA head antigenic sites. Interestingly, antigen was 5 1 4 cleared more quickly in the SC18 group compared to the BR07 group (p = 0.0001; S2 5 1 5 Fig B) suggesting that pre-existing cross-reactive immunity affects antigen load, and 5 1 6 may limit the duration of antigen stimulation. Overall, the BR07 primed group produced 5 1 7 a greater cross-reactive antibody response compared to the SC18 primed group due to 5 1 8 both an increase in cross-reactive stalk and head antigenic site specific antibodies. increased the cross-reactivity to historical antigens compared to the unperturbed 5 3 7
("Normal") model (Fig 4A) although stalk-specific antibody was decreased compared to 5 3 8 "Normal" model ( Fig 4C) . Removal of antibody clearance for the SC18 group also 5 3 9
increased antibody cross-reactivity, but to a lesser extent compared to the "No Memory" 5 4 0 model (Fig 4A) . For the BR07 group, removal of antibody clearance also increased the 5 4 1 cross-reactive response, but unlike the SC18 group, removal of memory B cells from 5 4 2 the germinal centers drastically decreased the cross-reactive response (Fig 4B) . Stalk- 
0 6
Lastly, although the change in epitopic distance of head epitopes is thought to be 6 0 7 the cause of the increase in stalk-antigenic site specific antibodies seen after boosting 6 0 8 with CA09 in the BR07 group in our simulations, the extent that antigenic change in the 6 0 9
head increases antibody responses to the stalk was not directly tested. Therefore, to 6 1 0 evaluate the effect of epitopic distance of head antigenic sites on the stalk-specific 6 1 1 antibody response, a two-antigenic-site antigen (head and stalk) was used. All 6 1 2 parameters were kept constant except the epitopic distance of the head antigenic site, 6 1 3 which was increased from 0 (fully conserved) to 10 (highly variable). Stalk antigenic 6 1 4 site-specific antibody increased linearly as epitopic distance was increased from 0 to 5 6 1 5 (over 200% increase) and plateaued when epitopic distance was increased beyond 5 6 1 6 (Fig 5D) . Therefore, the epitopic distance between head antigenic sites greatly affects 6 1 7 antibody responses to the stalk.
1 8
Taken together, epitopic distance increases of the head epitope had the largest 6 1 9 effect on stalk antigenic site specific antibody levels after boosting. Although all 6 2 0 parameters demonstrated some effect on the stalk-antigenic site specific antibodies, 6 2 1 these were modest when compared to the effect of epitopic distance. The decrease in 6 2 2 stalk antigenic site specific antibodies when the number of head antigenic sites was 6 2 3 increased may lend itself to the still unanswered question in the field of how difference 6 2 4 in the ratio of head to stalk epitopes of HA affects the subdominance of the stalk 6 2 5 antigenic site. If indeed the head contains more antigenic sites than the stalk, the model 6 2 6 predicts that stalk-antigenic site response will be decreased. It is important to note that 6 2 7 this analysis demonstrates stalk-antigenic site-specific antibody truly decreases with the 6 2 8 addition of head antigenic sites, and it is not only that stalk-specific antibodies remain 6 2 9 constant and only the relative amount compared to the head is changed. It also 6 3 0 suggests that the immunologic subdominance of the stalk does not necessarily mean it 6 3 1 is inherently less immunogenic, having implications for targeting this domain in universal 6 3 2 vaccination.
3 3
Predicting Antibody Responses 6 3 4
Although not the primary aim of this work, the fact that our simulations stem from 6 3 5 real life virus strains allows us to explore the possibility of using such an algorithm to 6 3 6 predict immune responses to real life vaccines. Perfect validation would require 6 3 7 specimens from age-matched subjects after vaccination with monovalent CA09 vaccine 6 3 8 with documented exposure histories or accurately measured antibody and memory B 6 3 9 cell repertoires, but this is not currently possible. Therefore, we attempted to determine 6 4 0 if the simulations can be used to accurately predict the increase in stalk-specific 6 4 1 antibody and increased cross reactivity seen in the BR07 exposed groups by using an 6 4 2 age-stratified cohort under the assumption that those born prior to 1947 were originally 6 4 3 exposed to 1918-like strains and those born after 1977 were exposed to the more 6 4 4 BR07-like recent strains. Specifically, serum was collected from an age-stratified cohort vaccination. Antibody levels were measured against recombinant HA proteins derived 6 4 8 0 from historical antigens via ELISA. We report the relative change in antibody (d28/d0) in 6 4 9 order to account for age-specific differences in basal antibody cross-reactivity.
5 0
The similarity and differences in the responses of each group was assessed first.
5 1
Although the sample size for the two groups was limited (n = 8 and n = 9), the 18-32 6 5 2 group clustered separately from the 60+ group by hierarchical clustering although this 6 5 3 grouping was not exact (Fig 6A) . Consistent with our model's findings, cross-reactivity 6 5 4 was generally increased in the BR07 representative group except for FM47, NC99, and 6 5 5 BR07 in which both groups had similar levels ( Fig 6B) . Stalk specific antibody 6 5 6 responses were measured using chimeric HA proteins that contained an "exotic" HA 6 5 7
head but retained the conserved stalk region (cH9.1 and cH6.1, Fig 6B) . The BR07 6 5 8 group had an increased response to the stalk region compared to the SC18 group for 6 5 9 both chimeras, although this was more pronounced in the cH9.1 assay. These findings 6 6 0 were consistent with the increase in stalk-specific antibody in the BR07 primed group 6 6 1 compared to the SC18 primed group in the model. Although our validation cohort was 6 6 2 underpowered, and differences did not reach statistical significance (with the exception 6 6 3 of NC99, t-test p=0.049), we found that the qualitative trends of the data match closely 6 6 4
with that of the model. This suggests that the model can at least qualitatively predict 6 6 5 differences in the cross-reactivity and relative stalk-specific antibody of secondary 6 6 6 immune responses. 6 6 7 6 6 8 
